Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reetta Huttunen

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
BMC Infectious Diseases|November 14, 2025
Streptococcus dysgalactiae subsp. equisimilis bacteremia in Finland: changes in emm-type distribution combined with clinical presentationViivi Nevanlinna, Janne Aittoniemi, Reetta Huttunen, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 28, 2025
Streptococcus dysgalactiae subsp. equisimilis bacteremia: emm types and clinical characteristics - a four-year prospective studyMiia Saukkosaari, Janne Aittoniemi, Reetta Huttunen, et al.
Shock (Augusta, Ga.)|October 2, 2008
Endothelial nitric oxide synthase G894T (GLU298ASP) polymorphism is associated with hypotension in patients with E. coli bacteremia but not in bacteremia caused by a gram-positive organismReetta Huttunen, Mikko Hurme, Janne Laine, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|January 3, 2023
Plasma soluble urokinase-type plasminogen activator receptor (P-suPAR) in the diagnostics between malignant and non-malignant pancreatic lesionsAnu Aronen, Janne Aittoniemi, Reetta Huttunen, et al.
Infectious Diseases (London, England)|July 3, 2015
Combined interventions are effective in MRSA controlElina Jokinen, Janne Laine, Reetta Huttunen, et al.
Infectious Diseases (London, England)|March 10, 2017
Comparison of outcome and clinical characteristics of bacteremia caused by methicillin-resistant, penicillin-resistant and penicillin-susceptible Staphylococcus aureus strainsElina Jokinen, Janne Laine, Reetta Huttunen, et al.
Plos One|January 24, 2013
Pentraxin 3 (PTX3) is associated with severe sepsis and fatal disease in emergency room patients with suspected infection: a prospective cohort studyRaija Uusitalo-Seppälä, Reetta Huttunen, Janne Aittoniemi, et al.
Plos One|March 23, 2011
High plasma level of long pentraxin 3 (PTX3) is associated with fatal disease in bacteremic patients: a prospective cohort studyReetta Huttunen, Mikko Hurme, Janne Aittoniemi, et al.
Infection|April 23, 2024
Assessment of a novel BLOOMY score for predicting mortality in hospitalised adults with bloodstream infectionJohanna Tietäväinen, Tapio Seiskari, Janne Aittoniemi, et al.
Plos One|February 13, 2014
High cell-free DNA predicts fatal outcome among Staphylococcus aureus bacteraemia patients with intensive care unit treatmentErik Forsblom, Janne Aittoniemi, Eeva Ruotsalainen, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
BMC Infectious Diseases|November 14, 2025
Streptococcus dysgalactiae subsp. equisimilis bacteremia in Finland: changes in emm-type distribution combined with clinical presentationViivi Nevanlinna, Janne Aittoniemi, Reetta Huttunen, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 28, 2025
Streptococcus dysgalactiae subsp. equisimilis bacteremia: emm types and clinical characteristics - a four-year prospective studyMiia Saukkosaari, Janne Aittoniemi, Reetta Huttunen, et al.
Shock (Augusta, Ga.)|October 2, 2008
Endothelial nitric oxide synthase G894T (GLU298ASP) polymorphism is associated with hypotension in patients with E. coli bacteremia but not in bacteremia caused by a gram-positive organismReetta Huttunen, Mikko Hurme, Janne Laine, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|January 3, 2023
Plasma soluble urokinase-type plasminogen activator receptor (P-suPAR) in the diagnostics between malignant and non-malignant pancreatic lesionsAnu Aronen, Janne Aittoniemi, Reetta Huttunen, et al.
Infectious Diseases (London, England)|July 3, 2015
Combined interventions are effective in MRSA controlElina Jokinen, Janne Laine, Reetta Huttunen, et al.
Infectious Diseases (London, England)|March 10, 2017
Comparison of outcome and clinical characteristics of bacteremia caused by methicillin-resistant, penicillin-resistant and penicillin-susceptible Staphylococcus aureus strainsElina Jokinen, Janne Laine, Reetta Huttunen, et al.
Plos One|January 24, 2013
Pentraxin 3 (PTX3) is associated with severe sepsis and fatal disease in emergency room patients with suspected infection: a prospective cohort studyRaija Uusitalo-Seppälä, Reetta Huttunen, Janne Aittoniemi, et al.
Plos One|March 23, 2011
High plasma level of long pentraxin 3 (PTX3) is associated with fatal disease in bacteremic patients: a prospective cohort studyReetta Huttunen, Mikko Hurme, Janne Aittoniemi, et al.
Infection|April 23, 2024
Assessment of a novel BLOOMY score for predicting mortality in hospitalised adults with bloodstream infectionJohanna Tietäväinen, Tapio Seiskari, Janne Aittoniemi, et al.
Plos One|February 13, 2014
High cell-free DNA predicts fatal outcome among Staphylococcus aureus bacteraemia patients with intensive care unit treatmentErik Forsblom, Janne Aittoniemi, Eeva Ruotsalainen, et al.
Pageof 5